2 insider filings
Nur Nicholson, insider filing for KLRA
Show all 2
- 4Insider filing for KLRA
- 3New insider at KLRA
Nur Nicholson, reporting
KLRA
Kailera Therapeutics, Inc. SEC filings
Every EDGAR filing for Kailera Therapeutics, Inc. (KLRA), newest first, with AI summaries and stories.
- Ticker
- KLRA
- CIK
- 2096997
- Latest filing
- Sep 9
Next: earnings expected ~May 20 · 10-Q expected ~May 20 (deadline May 17)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4Kailera Therapeutics, Inc.KLRALIVE ROUTINESCHEDULE 13GKailera Therapeutics, Inc.KLRALIVE Ownership stake disclosure by CANADA PENSION PLAN INVESTMENT BOARD
CANADA PENSION PLAN INVESTMENT BOARD, filed by
ROUTINESCHEDULE 13GKailera Therapeutics, Inc.KLRALIVE Ownership stake disclosure by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP, filed by
NOTABLE10-QKailera Therapeutics, Inc.KLRALIVE ROUTINE8-KKailera Therapeutics, Inc.KLRALIVE ROUTINESCHEDULE 13GKailera Therapeutics, Inc.KLRALIVE Ownership stake disclosure by Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd., filed by
ROUTINE4Kailera Therapeutics, Inc.KLRALIVE 2 insider filings
Kathleen Tregoning, insider filing for KLRA
Show all 2
- 4Insider filing for KLRA
- 3New insider at KLRA
Kathleen Tregoning, reporting
ROUTINE4Kailera Therapeutics, Inc.KLRALIVE Ronald C Renaud JR, insider filing for KLRA
Ronald C Renaud Jr, reporting
NOTABLE10-QKailera Therapeutics, Inc.KLRALIVE ROUTINE8-KKailera Therapeutics, Inc.KLRALIVE NOTABLESCHEDULE 13DKailera Therapeutics, Inc.KLRALIVE Ownership stake disclosure by BCLS Fund IV Investments, L.P.
BCLS Fund IV Investments, L.P., filed by
NOTABLESCHEDULE 13DKailera Therapeutics, Inc.KLRALIVE Ownership stake disclosure by BCPE Perseus Investor, LP
BCPE Perseus Investor, LP, filed by
ROUTINE4Kailera Therapeutics, Inc.KLRALIVE RTW INVESTMENTS, LP, insider filing for KLRA
RTW INVESTMENTS, LP, reporting · Roderick Wong, reporting
ROUTINE4Kailera Therapeutics, Inc.KLRALIVE Jiangsu Hengrui Pharmaceuticals Co., Ltd., insider filing for KLRA
Jiangsu Hengrui Pharmaceuticals Co., Ltd., reporting
ROUTINE4Kailera Therapeutics, Inc.KLRALIVE 15 insider filings
BAIN CAPITAL INVESTORS LLC, insider filing for KLRA
Show all 15
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
- 4Insider filing for KLRA
BAIN CAPITAL INVESTORS LLC, reporting · Bain Capital Fund XIV, L.P., reporting · +3 more
ROUTINE8-KKailera Therapeutics, Inc.KLRALIVE ROUTINE424B4Kailera Therapeutics, Inc.KLRALIVE ROUTINES-8Kailera Therapeutics, Inc.KLRALIVE ROUTINEEFFECTKailera Therapeutics, Inc.KLRALIVE ROUTINE3Kailera Therapeutics, Inc.KLRALIVE 15 insider filings
Jiangsu Hengrui Pharmaceuticals Co., Ltd., new insider at KLRA
Show all 15
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
- 3New insider at KLRA
Jiangsu Hengrui Pharmaceuticals Co., Ltd., reporting